QSAR Studies on Keto Sulfones Derivatives as Inhibitors of 11?Ž?²- Hydroxysteroid Dehydrogenase Type 1 | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


QSAR Studies on Keto Sulfones Derivatives as Inhibitors of 11?Ž?²- Hydroxysteroid Dehydrogenase Type 1

Author(s): Shashank Trivedi, Prakash C. Patidar, Pradeep K. Chaurasiya, Rajesh S. Pawar, Umesh K. Patil, Pradeep K. Singour

Metabolic disorders, such as obesity and type 2 diabetes, have assumed epidemic proportions and present major challenges for healthcare systems. The keto sulfones derivatives were discovered as potent and selective 11β-HSD1 inhibitors. The studies show that these compounds are not active against 11β-HSD2 and thus easily surpass the side effects of inhibition of 11β- HSD2 such as sodium retention, hypokalemia and hypertension. So here we have tried to explore the series of β- keto sulfones derivatives, to develop novel, selective and potent orally active compounds through QSAR analysis. The QSAR study carried out on 23 keto sulfones derivatives as inhibitors of 11β-HSD. Molecular modeling studies were performed using chemoffice 6.0 supplied by cambridgesoft. The sketched structures were subjected to energy minimization & the lowest energy structure was used to calculate the physiochemical properties. The regression analysis was carried out using a computer program called SYSTAT 10.2. The best models were selected from the various statistically significant equations. The study revealed that the LUMO, Dipole-dipole energy, NVDW contributed positively, and Heat of formation contributed negatively. The analysis resulted in 2-D equation, which suggests that, n=16, r=0.953, r2=0.909, Standard error of estimate(s)=0.342 & validated r2(q2) =0.7135. This study can help in rational drug design and synthesis of new selective 11β-HSD1 with predetermined affinity.


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry